Homechevron_rightAll Peptideschevron_rightIpamorelin Injection Pen

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-ipamorelin-injection-pen-5mg

Official Product Data Sheet

Ipamorelin Injection Pen (5mg)

High >98% Purity

Vial Contents

5 mg Ipamorelin (3 mL pre-filled injection pen)

Includes

Ready-to-use multi-dose injection pen — no mixing required

Form

Pre-filled multi-dose pen

Purity

≥98%, third-party verified

Sequence

Growth Hormone Secretagogue

Molecular Formula

See chemical properties

Molecular Mass

711.85 g/mol

CAS No.

170851-70-4

Solubility

Concentration: ≈1.67 mg/mL | Per click: 1 unit ≈ 16.67 mcg (0.016 mg)

Storage

Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

swipe_rightSwipe to see all tabs

Scientific Background

Ipamorelin is a highly selective growth hormone secretagogue peptide that activates ghrelin/GHS receptors to stimulate pulsatile GH release — without affecting cortisol, prolactin, or ACTH. This selectivity makes it one of the cleanest GHRP research compounds available, ideal for studying pulsatile GH physiology, body composition, and recovery.

Intended Research Use

Selective ghrelin/GHS receptor activation research
Pulsatile GH secretion studies
Body composition and lean mass preservation research
Recovery and tissue repair studies
GH axis research without cortisol or prolactin interference

menu_bookScientific Publications

article

Eur J Endocrinol (1998)

Ipamorelin, the first selective growth hormone secretagogue

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/9849822/

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

Ipamorelin's GHRP activity pairs synergistically with GHRH analogs for amplified GH release.

CJC-1295 (no DAC) (2mg vial)

arrow_forward

myo-cjc-1295-no-dac-2mg

Classic GHRH + GHRP synergy — CJC-1295 activates GHRH receptors while Ipamorelin activates ghrelin/GHS receptors for complementary, amplified pulsatile GH release.